Coherus Confident On Avastin This Year With Humira Goal Achieved

Filing Of Adalimumab Was Slated For Q4 2020

 
• By Dean Rudge
  
Light bulb
Coherus is aiming to file its partnered bevacizumab in the back half of this year. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products